Last reviewed · How we verify
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)
The purpose of this study is to discuss the prognostic value of CEPH among HCC patients underwent TACE treatment, its impact on overall survival, and try to stratify patient cohorts for a better treatment strategy.
Details
| Lead sponsor | Zhongda Hospital |
|---|---|
| Status | UNKNOWN |
| Enrolment | 228 |
| Start date | Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hepatocellular Carcinoma
- Portal Hypertension
Interventions
- TACE ± Systemic therapy
Countries
China